Stock Comparison
EXEL vs REGN
Exelixis Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.80B
$80.55B
P/E (TTM)
16.3
19.4
Forward P/E
16.3
17.1
Price/Sales
5.3
5.2
Price/Book
7.0
2.5
EV/EBITDA
11.9
13.1
Dividend Yield
—
0.45%
Profitability
Net Margin
35.33%
29.65%
Operating Margin
39.88%
24.32%
Return on Equity
44.40%
14.00%
Return on Assets
24.00%
6.53%
Growth (YoY)
Revenue Growth
10.60%
16.70%
Earnings Growth
26.20%
-4.50%
Price & Risk
Beta
0.4
0.2
52-Week High
$57.10
$810.12
52-Week Low
$34.54
$553.38
Analyst Target
$52.88
$833.54
Compare EXEL and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.